These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 9177263)

  • 1. HCV NS5A abrogates p53 protein function by interfering with p53-DNA binding.
    Gong GZ; Jiang YF; He Y; Lai LY; Zhu YH; Su XS
    World J Gastroenterol; 2004 Aug; 10(15):2223-7. PubMed ID: 15259070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 Activation in Genetic Disorders: Different Routes to the Same Destination.
    Tsai YY; Su CH; Tarn WY
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional inhibition of p21WAF1/CIP1 gene (CDKN1) expression by survivin is at least partially p53-dependent: evidence for survivin acting as a transcription factor or co-factor.
    Tang L; Ling X; Liu W; Das GM; Li F
    Biochem Biophys Res Commun; 2012 May; 421(2):249-254. PubMed ID: 22503977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical profiling of benign, low malignant potential and low grade serous epithelial ovarian tumors.
    Ouellet V; Ling TH; Normandin K; Madore J; Lussier C; Barrès V; Bachvarov D; Rancourt C; Tonin PN; Provencher DM; Mes-Masson AM
    BMC Cancer; 2008 Nov; 8():346. PubMed ID: 19032793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The individualization of cancer therapy: the unexpected role of p53.
    Hait WN; Yang JM
    Trans Am Clin Climatol Assoc; 2006; 117():85-101; discussion 101. PubMed ID: 18528466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tyrphostin AG 1024 modulates radiosensitivity in human breast cancer cells.
    Wen B; Deutsch E; Marangoni E; Frascona V; Maggiorella L; Abdulkarim B; Chavaudra N; Bourhis J
    Br J Cancer; 2001 Dec; 85(12):2017-21. PubMed ID: 11747348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple pathways control cell growth and transformation: overlapping and independent activities of p53 and p21Cip1/WAF1/Sdi1.
    Cox LS
    J Pathol; 1997 Oct; 183(2):134-40. PubMed ID: 9390024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Human gene p53].
    Berbeć H
    Postepy Biochem; 1994; 40(1):6-11. PubMed ID: 8208639
    [No Abstract]   [Full Text] [Related]  

  • 9. Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage.
    Seoane J; Le HV; Massagué J
    Nature; 2002 Oct; 419(6908):729-34. PubMed ID: 12384701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 mutants can often transactivate promoters containing a p21 but not Bax or PIG3 responsive elements.
    Campomenosi P; Monti P; Aprile A; Abbondandolo A; Frebourg T; Gold B; Crook T; Inga A; Resnick MA; Iggo R; Fronza G
    Oncogene; 2001 Jun; 20(27):3573-9. PubMed ID: 11429705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A transcriptional activation function of p53 is dispensable for and inhibitory of its apoptotic function.
    Kokontis JM; Wagner AJ; O'Leary M; Liao S; Hay N
    Oncogene; 2001 Feb; 20(6):659-68. PubMed ID: 11313999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the molecular mechanisms for p53-mediated differentiation.
    Chylicki K; Ehinger M; Svedberg H; Gullberg U
    Cell Growth Differ; 2000 Nov; 11(11):561-71. PubMed ID: 11095245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperinducibility of hypoxia-responsive genes without p53/p21-dependent checkpoint in aggressive prostate cancer.
    Salnikow K; Costa M; Figg WD; Blagosklonny MV
    Cancer Res; 2000 Oct; 60(20):5630-4. PubMed ID: 11059752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro transcriptional activation of p21 promoter by p53.
    Kim TK
    Biochem Biophys Res Commun; 1997 May; 234(2):300-2. PubMed ID: 9177263
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.